Commercial Excellence Resources

When the COVID pandemic hit, the marketing team at an F150 biopharma company shifted its speaker and educational programs to a virtual format. However, the team then recognized that the content...

How can pharma marketers remain effective and relevant for key customers, patients, and healthcare providers (HCPs) in the time of COVID-19?

On-demand talent is a critical resource for life science and pharma companies as they innovate to keep pace with market changes, respond to emerging health threats, and adapt to a remote environment.

Independent talent provide an agile source of critical skills that allow life science leaders to keep pace in a fast-changing environment.

In an effort to inform its Rare Diseases commercial strategy within a specific country, an F100 pharmaceutical company was looking to gain a deeper understanding of the current competitive...

Commercial strategy leaders must prepare now to ensure success for potential COVID-19 treatments. Biopharma expert Marc Cooley shares what life science companies should keep in mind at this moment.

COVID-19 is sidelining the field reps that life science companies rely on for in-person pharmaceutical detailing. Healthcare marketing strategist Martine Taylor discusses how eDetailing can help.

Independent biopharma marketer Kimberly Crichton explains how technology is changing the way life science companies launch products and communicate with consumers and healthcare providers.

Life Science project leader Ron Niesen discusses pharma product launch best practices, from gathering data to streamlining decisions.

Independent commercial operations expert David Davidovic talks about assessing new technologies, making fast decisions, and building commercial centers of excellence.

These days, you'd be hard-pressed to find a life science company that doesn't strive for patient centricity. But what does patient-centric marketing mean?

The lines are blurring between U.S. healthcare payers and providers. What does this payer/provider consolidation mean for pharma? Nothing less than a total shift in the way it does business. If...

A major biopharmaceutical company had developed a breakthrough medication that stood to dramatically disrupt the market for its therapeutic area. Expected to be approved by the FDA in the next...